RetinalGenix Technologies Inc. Quarterly Return On Equity in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
RetinalGenix Technologies Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2024.
  • RetinalGenix Technologies Inc. Return On Equity for the quarter ending September 30, 2024 was 243 %, a 48% increase year-over-year.
  • RetinalGenix Technologies Inc. annual Return On Equity for 2023 was 145 %, a 67.3% decline from 2022.
  • RetinalGenix Technologies Inc. annual Return On Equity for 2022 was 444 %, a 40.6% decline from 2021.
  • RetinalGenix Technologies Inc. annual Return On Equity for 2021 was 747 %, a 92.3% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 243 +78.6 +48% Jul 1, 2024 Sep 30, 2024
Q2 2024 278 -21.6 -7.23% Apr 1, 2024 Jun 30, 2024
Q1 2024 258 -119 -31.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 145 -299 -67.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 164 -335 -67.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 299 +1.37 +0.46% Apr 1, 2023 Jun 30, 2023
Q1 2023 376 -80.7 -17.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 444 -303 -40.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 499 -718 -59% Jul 1, 2022 Sep 30, 2022
Q2 2022 298 -3.76K -92.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 457 -2.33K -83.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 747 -8.94K -92.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 1.22K Jul 1, 2021 Sep 30, 2021
Q2 2021 4.06K Apr 1, 2021 Jun 30, 2021
Q1 2021 2.79K Jan 1, 2021 Mar 31, 2021
Q4 2020 9.69K Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.